Literature DB >> 7065738

Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065738      PMCID: PMC1030282          DOI: 10.1136/ard.41.suppl_1.1-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  162 in total

1.  Kaposi Sarcoma complicating systemic lupus erythematosus treated with immunosuppression.

Authors:  M B Klein; F A Pereira; I Kantor
Journal:  Arch Dermatol       Date:  1974-10

2.  Carcinoembryonic antigen in rheumatoid arthritis.

Authors:  A Unger; G S Panayi; M H Lessof
Journal:  Lancet       Date:  1974-04-27       Impact factor: 79.321

3.  The nephrotic syndrome, malignancy and immunosuppression.

Authors:  R Rabkin; G N Thatcher; L H Diamond; L Eales
Journal:  S Afr Med J       Date:  1973-04-14

4.  Hazard of immunosuppressive therapy.

Authors:  N Manny; E Rosenman; J Benbassat
Journal:  Br Med J       Date:  1972-04-29

5.  Preliminary results with azathioprine treatment in rheumatoid arthritis.

Authors:  A J Swannell; G D Kersley
Journal:  Ann Phys Med       Date:  1969-11

6.  Latent carcinoma of the prostate in a 24-year-old man receiving cyclophosphamide and azathioprine.

Authors:  G B Elliott; D S Silverberg; J B Dossetor; C S Muir
Journal:  Can Med Assoc J       Date:  1977-03-19       Impact factor: 8.262

7.  Azathioprine in the treatment of chronic polyarthritis: longterm results and adverse effects in 25 patients.

Authors:  R S Pinals
Journal:  J Rheumatol       Date:  1976-06       Impact factor: 4.666

8.  Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis.

Authors:  K M GOEBEL; R Janzen; K Joseph; U Börngen
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

Review 9.  Musculoskeletal syndromes associated with malignancy.

Authors:  D S Caldwell
Journal:  Semin Arthritis Rheum       Date:  1981-02       Impact factor: 5.532

10.  Enhancement of antibody synthesis by 6-mercaptopurine.

Authors:  D Chanmougan; R S Schwartz
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Treatment of systemic lupus erythematosus.

Authors:  P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

Review 2.  Immunosuppressive therapy in the treatment of autoimmune diseases.

Authors:  P A Miescher; P Beris
Journal:  Springer Semin Immunopathol       Date:  1984
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.